Dr. Öğr. Ü. Mert Öztaş
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
COVID-19 4 publicationsSource: OpenAlex / PubMed MeSHView publications
- Familial Mediterranean Fever 3 publications
- Rheumatic Diseases 2 publications
- Behcet Syndrome 2 publications
- Giant Cell Arteritis 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Vaskülit (Damar İltihabı)
- Behçet Hastalığı
- Ailesel Akdeniz Ateşi (FMF)
- Ankilozan Spondilit
- Romatoid Artrit
CV
Education and experience
Experience
- 2023Acıbadem Sağlık Grubuacibadem.com.tr
- 2021 - 2023Sağlık Bilimleri Üniversitesi İstanbul Eğitim ve Araştırma Hastanesiacibadem.com.tr
- 2018 - 2021İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Romatolojiacibadem.com.tr
- 2013 - 2018İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İç Hastalıklarıacibadem.com.tr
- 2012Devrek Devlet Hastanesiacibadem.com.tr
Education
- 2021İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Romatoloji, Üst Uzmanlıkacibadem.com.tr
- 2018İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 2012İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyRheumatologyacibadem.com.trFrom source
- InstitutionAcıbadem Maslak Hastanesi, Acıbadem Atakent Hastanesi, Acıbadem Ataşehir Hastanesiacibadem.com.trFrom source
- Area of workCOVID-19Extracted from 4 publications · Model version —From source
- Publications22 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:51https://www.acibadem.com.tr/doktor/mert-oztas/acibadem.com.tr
Scientific work
Publications on COVID-19
-
Impact of SAA versus CRP in evaluation of acute-phase response in familial Mediterranean fever
Medicine, 2026
DOI 10.1097/md.0000000000050309 PMID 42629676 Open-access full textSource: OpenAlex
-
Musculoskeletal Manifestations in Behçet’s Syndrome
Springer eBooks, 2025
DOI 10.1007/978-3-031-77251-1_14 Source: OpenAlex
-
Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience
International Journal of Rheumatic Diseases, 2023
DOI 10.1111/1756-185x.14798 PMID 37358327 2 citations (Europe PMC) Source: OpenAlex
-
Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine
Journal of Medical Virology, 2022
DOI 10.1002/jmv.27731 PMID 35315100 5 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors
Rheumatology, 2022
DOI 10.1093/rheumatology/keac123 PMID 35258567 3 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey
Rheumatology International, 2021
DOI 10.1007/s00296-021-04841-3 PMID 33779780 82 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
Rheumatology International, 2021
DOI 10.1007/s00296-021-04910-7 PMID 34109466 68 citations (Europe PMC) Open-access full textSource: OpenAlex
-
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome
Rheumatology International, 2021
DOI 10.1007/s00296-021-05056-2 PMID 34825278 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center
TURKISH JOURNAL OF MEDICAL SCIENCES, 2021
DOI 10.3906/sag-2102-263 PMID 36326373 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience
Clinical Lymphoma Myeloma & Leukemia, 2021
DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 citations (Europe PMC) Source: OpenAlex